All News
Filter News
Found 806,263 articles
-
Infectious Disease Expert Available to Comment on COVID-19 Delta Variant, Impact in Tokyo and Masking for Vaccinated and Unvaccinated Individuals
7/27/2021
Pia MacDonald, MPH, Ph.D., an infectious disease epidemiologist at RTI International, a nonprofit research institute, is available for media interviews on the future trajectory of the COVID-19 pandemic, the importance of vaccinations, and the impact of Delta variant and other virus variants on reaching herd immunity moving into the fall.
-
Council on Radionuclides and Radiopharmaceuticals, Inc. Supports the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021
7/27/2021
The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), along with physicians and patient organizations, supports the introduction of H.R. 4479, the “Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021” by Congressmen Scott Peters (D-CA), Bobby Rush (D-IL), Neal Dunn (R-FL) and Greg Murphy (R-NC).
-
Nektar to Announce Financial Results for the Second Quarter 2021 on Thursday, August 5, 2021, After Close of U.S.-Based Financial Markets
7/27/2021
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2021 on Thursday, August 5, 2021, after the close of U.S.-based financial markets.
-
Medicenna Announces That Initiation of MDNA11 Phase 1/2 Study is on Track; Update to be Provided at the PropThink Digital Conference
7/27/2021
Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, is providing an update on its MDNA11 program today
-
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
7/27/2021
Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the second quarter ended June 30, 2021 on Tuesday, August 10 2021.
-
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call
7/27/2021
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on Monday, August 9 at 4:30 p.m. ET / 1:30 p.m. PT.
-
Curis to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 3, 2021
7/27/2021
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its second quarter 2021 financial results on Tuesday, August 3, 2021, after the close of US markets.
-
NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
7/27/2021
NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced it plans to report second quarter financial results and provide a corporate update on Monday, August 9, 2021, via press release, after market close.
-
Health Catalyst to Announce Second Quarter 2021 Operating Results and Host Conference Call on Thursday, August 5, 2021
7/27/2021
Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 second quarter operating results on Thursday, August 5, 2021, after market close.
-
Augmedix to Report 2021 Second Quarter Financial Results on August 10, 2021
7/27/2021
Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced it will report financial results for the second quarter 2021 on Tuesday, August 10, 2021 after market close.
-
Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
7/27/2021
Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12 at 3:30 p.m. ET and the Morgan Stanley Virtual Global Healthcare Conference on Friday, September 10 at 9:30 a.m. ET. Both events are virtual conferences.
-
Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021
7/27/2021
Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021.
-
Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
7/27/2021
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2021 conference call on Wednesday, August 4, at 7:30 a.m. CT (8:30 a.m. ET).
-
Allogene Therapeutics to Report Second Quarter Financial Results on August 4, 2021Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ET
7/27/2021
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will report second quarter 2021 financial results on Wednesday, August 4, 2021, after the close of the market.
-
Vyant Bio to Present at A.G.P.’s Virtual MedTech Summer Conference
7/27/2021
Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging leader in novel drug discovery, is pleased to announce that Jay Roberts, Chief Executive Officer, will present at A.G.P.’s Virtual MedTech Summer Conference hosted by Alliance Global Partners (A.G.P) on Thursday, July 29, 2021.
-
Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021Management to host conference call and webcast at 8:30 AM ET on that day
7/27/2021
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces that it will release its second quarter 2021 financial and operating results for the period ended June 30, 2021 on Tuesday, August 10, 2021 prior to the start of trading.
-
Rhythm Pharmaceuticals to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
7/27/2021
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 3, 2021 to report its second quarter 2021 financial results and provide a corporate update.
-
Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress
7/27/2021
Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present clinical and pre-clinical data, including updated analyses from the Phase 2 STRIVE study and an in vitro evaluation of rezafungin activity against Candida and Aspergillus spp.
-
Infinity Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Company Update
7/27/2021
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced its second quarter 2021 financial results and provided a corporate update.
-
Kinnate Biopharma Inc. to Participate in the 2021 Wedbush PacGrow Healthcare Conference
7/27/2021
Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced that its Chief Executive Officer Nima Farzan will participate in the 2021 Wedbush PacGrow Healthcare Conference, being held virtually from August 10-11, 2021.